Michael Gelband’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Michael Gelband’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,132	Closed	-$377K	–	2181
2024 Q3	$377K	Buy	+33,132	New	+$333K	﹤0.01%	1289
2023 Q2	–	Sell	-17,944	Closed	-$337K	–	2326
2023 Q1	$337K	Buy	+17,944	New	+$295K	﹤0.01%	1445
2022 Q3	–	Sell	-176,472	Closed	-$2.69M	–	2387
2022 Q2	$2.69M	Buy	+176,472	New	+$2.61M	0.03%	650
2021 Q4	–	Sell	-221,509	Closed	-$4.78M	–	2695
2021 Q3	$4.78M	Buy	221,509 +129,424	+141%	+$3.12M	0.06%	416
2021 Q2	$2.36M	Buy	92,085 +10,954	+14%	+$234K	0.03%	605
2021 Q1	$1.48M	Buy	81,131 +59,517	+275%	+$989K	0.02%	704
2020 Q4	$249K	Buy	+21,614	New	+$198K	﹤0.01%	1627

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.39B AUM 53.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Michael Gelband's CDMO Position: Q4 2024 in Review

Michael Gelband sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 33,132 shares — an estimated $377K sold.

Michael Gelband first reported a position in CDMO in Q4 2020 and held it in 7 quarters. The position peaked at $4.78M in Q3 2021. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

Michael Gelband reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Michael Gelband sold 33,132 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $377K.
Michael Gelband first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Michael Gelband's Avid Bioservices, Inc. Common Stock position peaked at $4.78M in Q3 2021.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.